论文信息 - The CDK9 Inhibitor Dinaciclib Exerts Potent Apoptotic and Antitumor Effects in Preclinical Models of MLL-Rearranged Acute Myeloid Leukemia. - 字舞流文

The CDK9 Inhibitor Dinaciclib Exerts Potent Apoptotic and Antitumor Effects in Preclinical Models of MLL-Rearranged Acute Myeloid Leukemia.

L. Kats | J. Zuber | R. Johnstone | R. Lock | J. Shortt | I. Verbrugge | G. Gregory | E. Vidacs | Erwin M. Lee | A. Baker | J. Hilton | Adele J. Baker | Eva Vidacs | Lev M. Kats